Anal fissures, piles, abscesses, and fistulas differ in pain, bleeding, and infection, know the signs early.

March 28 (Reuters) - Incyte said on Saturday its experimental skin disease drug showed long-term reduction of symptoms in two late-stage trials. The company tested the drug, povorcitinib, in patients ...

Insmed will discontinue a program evaluating brensocatib to treat a chronic inflammatory skin condition after a Phase 2b study failed to meet its primary or secondary endpoints. The biopharmaceutical ...

Add Yahoo as a preferred source to see more of our stories on Google. Aleisha's mother said she was "an amazing mummy" to Xavier [PA Media] A young mother died from sepsis contributed to by NHS ...

Two posters demonstrated povorcitinib's durable 54-week efficacy and a favorable safety profile in moderate to severe HS, including patients previously on anti-TNF therapy. HS, a chronic, recurrent ...

Presentations at the 2026 meeting of the American Academy of Dermatology not only demonstrate the therapeutic potential of ...

Results from the Phase 3 VELA clinical trials in adults with moderate-to-severe hidradenitis suppurativa (HS) show that clinical responses ...

Insmed Incorporated (INSM) said on Tuesday that its mid-stage study evaluating brensocatib in adult patients with moderate to ...

Last year, Financial Times reported that big pharma company Merck had attempted to acquire MoonLake for over $3 billion ...

Scientists created samples of the black resin using three methods and tested their effectiveness against two common bacteria ...

A judge called a recess to the trial of a former Phoenix police officer and his wife after problems noted in with evidence.

Swans are suffering from infections caused by concrete riverbanks that feel like "broken glass", according to a wildlife ...